Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Programme
Alcohol
Behavioural addictions
Cannabis
Capacity-building
Comorbidity
COVID-19
Crime
Criminal justice/prisons
E-health
Epidemiology
Gender issues
Harm reduction
Health consequences
Hepatitis
HIV
Infectious diseases
Markets
Medicines
Mental health
New psychoactive substances
Nicotine/tobacco
Non-substance related addictions
Overdose prevention
Policy
Prevention
Public health
Treatment
User perspectives
Vulnerable groups
Youth
Apply
Reset
WED
23 NOV
THU
24 NOV
FRI
25 NOV
Filter by sessions
All
Plenary session
Big debate
Structured session
Workshop
Oral presentation session
Short communication session
e-short communications
e-poster guided tour
e-posters
PDF version
Wed 23 Nov
08:00
Arrival and registration
08:00
to
09:00
NETWORKING ZONE
08:30
Official opening
08:30
to
09:00
Main stage
Plenary session
09:00
Ensuring adequate pain relief whilst reducing addiction risk: lessons learnt and the way forward
09:00
to
10:30
Main stage
Plenary session
e-posters — day 1
09:00
to
19:30
Digital kiosks
e-poster session
e-short communications — day 1
09:00
to
19:30
Digital kiosks
e-short communication session
10:30
Coffee break
10:30
to
10:50
Coffee break
10:50
Drug policy: socio-political influence, cultural diversity
10:50
to
12:20
Insights zone 1 (I1)
InterGLAM cinema
Addressing substance use and substance use disorders in humanitarian settings: the role of evidence-based prevention, treatment and care
10:50
to
12:20
Insights zone 4 (I4)
Structured session
Advances in toxicology
10:50
to
12:20
Central square 2 (C2)
Oral presentation session
Commonalities across addictions
10:50
to
12:20
Insights zone 2 (I2)
Oral presentation session
COVID-19 implications for services and responses
10:50
to
12:20
Central square 3 (C3)
Oral presentation session
Current and future challenges associated with emerging cannabis markets
10:50
to
12:20
Main stage
Structured session
Drug treatment
10:50
to
12:20
Knowledge market 3 (K3)
Oral presentation session
Emerging changes in Europe's cannabis situation: policy preparedness and responses to a dynamic situation
10:50
to
12:20
Knowledge market 4 (K4)
Structured session
Foetal Alcohol Syndrome: piloting best practices towards FAS/FASD prevention. Results from the FAR SEAS European project
10:50
to
12:20
Central square 1 (C1)
Structured session
Gambling Research
10:50
to
12:20
Insights zone 3 (I3)
Oral presentation session
Gaming and gambling: Characteristics, harms, correlates, and treatment
10:50
to
12:20
Networking zone 2 (N2)
e-poster guided tour
Getting your addiction research published
10:50
to
12:20
Central square 4 (C4)
Workshop
Improving knowledge, taking action
10:50
to
12:20
Networking zone 1 (N1)
e-poster guided tour
Prescription opioids and overdose deaths
10:50
to
12:20
Knowledge market 1 (K1)
Structured session
Reaching out
10:50
to
12:20
Networking zone 4 (N4)
Short communication session
Substance use, mental health and mental well-being: observations, interventions and recovery promotion
10:50
to
12:20
Networking zone 3 (N3)
Short communication session
Substance-induced psychosis: register-linkage research in Nordic countries
10:50
to
12:20
Knowledge market 2 (K2)
Structured session
12:20
WHO lunch-time session
Alcohol: at the intersection of policy and science
12:20
to
13:10
Insights zone 4 (I4)
Lunch break
UNODC-WHO lunch-time session
Designing focused, tailored and prioritized HIV and viral hepatitis interventions for people who use drugs
12:20
to
13:10
Insights zone 3 (I3)
Lunch break
Lunch break
12:20
to
13:20
Lunch break
13:20
Assessing the impact of laws and policies regulating illicit drugs on health and society: some insights
13:20
to
14:50
Knowledge market 4 (K4)
Structured session
Cannabis
13:20
to
14:50
Networking zone 2 (N2)
e-poster guided tour
Cultures of prevention: training the workforce
13:20
to
14:50
Main stage
Structured session
Drug problems, perspectives and patterns of use
13:20
to
14:50
Networking zone 4 (N4)
Short communication session
Drug use in diverse communities and settings
13:20
to
14:50
Networking zone 1 (N1)
e-poster guided tour
e-/m-health interventions for substance use disorders
13:20
to
14:50
Central square 3 (C3)
Oral presentation session
Gambling epidemiology and new trends
13:20
to
14:50
Insights zone 3 (I3)
Oral presentation session
Global digital addiction interventions: adaptations to target audiences and effectiveness
13:20
to
14:50
Insights zone 2 (I2)
Structured session
Hepatitis C epidemiology and prevention
13:20
to
14:50
Knowledge market 3 (K3)
Oral presentation session
Migration, substance use and interventions in Europe
13:20
to
14:50
Insights zone 4 (I4)
Structured session
Policies for regulating cannabis supply in Europe and the US: the need for appropriate monitoring and evaluation
13:20
to
14:50
Knowledge market 1 (K1)
Structured session
Precision Medicine and Novel Approaches to the Treatment Alcohol Use Disorder
13:20
to
14:50
Central square 1 (C1)
Structured session
Prevention and control of infectious diseases among people who inject drugs: New evidence within the updated guidance from the ECDC and the EMCDDA
13:20
to
14:50
Networking zone 3 (N3)
Structured session
Special at-risk populations and need for diversified interventions to prevent overdoses: insights from the US and Europe, on fentanyl, suicidal overdoses and deaths among teen-agers
13:20
to
14:50
Central square 4 (C4)
Structured session
The future for Digital Addictions Services. An update from the DigitAS-DADE Project
13:20
to
14:50
Central square 2 (C2)
Structured session
14:50
Break
14:50
to
15:00
Break
15:00
Alcohol use and AUD during COVID-19 pandemic
15:00
to
16:30
Central square 1 (C1)
Oral presentation session
Convergence in behavioural addictions
15:00
to
16:30
Main stage
Structured session
Drug Early Warning Systems – the key to preparedness and response to new psychoactive substances
15:00
to
16:30
Central square 2 (C2)
Structured session
Estimating harm
15:00
to
16:30
Central square 3 (C3)
Oral presentation session
Estimating prevalence
15:00
to
16:30
Knowledge market 4 (K4)
Oral presentation session
How prepared are monitoring systems to respond to rapidly changing drug markets in regions bordering the European Union?
15:00
to
16:30
Insights zone 4 (I4)
Structured session
Implementation of quality standards in drug demand reduction – where we are and where we are going?
15:00
to
16:30
Knowledge market 1 (K1)
Structured session
INDRA: dialogues for an international didactic repository for addictions
15:00
to
16:30
Insights zone 2 (I2)
Structured session
Injecting-related infections and drug surveillance
15:00
to
16:30
Knowledge market 3 (K3)
Oral presentation session
Scenario Engagement Workshop
15:00
to
16:30
Central square 4 (C4)
Workshop
Short communications on alcohol: Covid, Ketamine, Cognition, Consumption
15:00
to
16:30
Networking zone 3 (N3)
Short communication session
Spillover effects of drug policy and why better data are needed
15:00
to
16:30
Networking zone 1 (N1)
e-poster guided tour
Substance use and mental health disorders in Europe: prevalence, models of care, and implementation in a challenging COVID-19 context
15:00
to
16:30
Knowledge market 2 (K2)
Structured session
Surveillance
15:00
to
16:30
Networking zone 4 (N4)
Short communication session
InterGLAM video session
The breadth of global addiction experiences
15:00
to
16:30
Insights zone 1 (I1)
InterGLAM cinema
Towards endemicity: A global perspective of the many variants of drug consumption rooms and service models in operation
15:00
to
16:30
Insights zone 3 (I3)
Structured session
Understanding relationships between substance use, mental health and mental illness: Session 1
15:00
to
16:30
Networking zone 2 (N2)
e-poster guided tour
16:30
Coffee break
16:30
to
16:50
Coffee break
16:50
Addiction and comorbidity over the lifespan: mechanisms and interventions
16:50
to
18:20
Central square 2 (C2)
Structured session
Alcohol use disorder treatment and its epidemiology
16:50
to
18:20
Central square 1 (C1)
Oral presentation session
Assessment of drug policies in light of Sustainable Development Goals and human rights
16:50
to
18:20
Knowledge market 1 (K1)
Structured session
Driving under the influence of cannabis (DUIC)
16:50
to
18:20
Insights zone 3 (I3)
Structured session
Drugs and community
16:50
to
18:20
Insights zone 2 (I2)
Oral presentation session
Economic recessions, COVID-19, socio-determinants of drug use and its harms: deaths of despair?
16:50
to
18:20
Central square 4 (C4)
Workshop
EU4MD Treatment facility survey
16:50
to
18:20
Networking zone 2 (N2)
Oral presentation session
Focusing on gender issues
16:50
to
18:20
Central square 3 (C3)
Oral presentation session
Hepatitis C prevention and treatment among people who inject drugs: Global progress and future requirements
16:50
to
18:20
Knowledge market 3 (K3)
Structured session
Impact and lessons learned in implementing and sustaining Needs-Based Planning models for substance use and mental health services and systems
16:50
to
18:20
Knowledge market 2 (K2)
Structured session
Improving knowledge, protecting health
16:50
to
18:20
Networking zone 3 (N3)
Short communication session
Improving the health of people who use drugs
16:50
to
18:20
Networking zone 4 (N4)
Short communication session
Scanner - Understanding the dynamics and consequences of new psychoactive substances in a rapidly changing (online) drug market
16:50
to
18:20
Insights zone 4 (I4)
Structured session
Treatment options for drug users in prisons in Central Asia and Germany
16:50
to
18:20
Networking zone 1 (N1)
Structured session
Why we need evidence-based approaches for the universal measurement of cannabis: rationale and implications for public health, treatment and research
16:50
to
18:20
Main stage
Structured session
18:20
Break
18:20
to
18:30
Break
18:30
Psychedelic-assisted treatment for substance use disorders – long overlooked or now overhyped?
18:30
to
19:30
Main stage
Big debate
19:30
Welcome cocktail with finger food
19:30
to
21:30
NETWORKING ZONE
Welcome cocktail
Thu 24 Nov
09:00
Contemporary Issues
09:00
to
10:30
Central square 2 (C2)
Oral presentation session
Developing the addiction workforce in Africa: Progress and Issues
09:00
to
10:30
Central square 4 (C4)
Workshop
Re-imagine recovery
09:00
to
10:30
Main stage
Plenary session
The Spanish Network on Research on Primary Attention on Addiction (RIAPAd): a new multilevel integrated model of responsible research on Addiction Disorders
09:00
to
10:30
Knowledge market 4 (K4)
Structured session
e-posters — day 2
09:00
to
19:30
Digital kiosks
e-poster session
e-short communications — day 2
09:00
to
19:30
Digital kiosks
e-short communication session
10:30
Coffee break
10:30
to
10:50
Coffee break
10:50
Alcohol and AUD during the life-cycle
10:50
to
12:20
Networking zone 3 (N3)
Short communication session
Alcohol policies
10:50
to
12:20
Central square 1 (C1)
Oral presentation session
Cannabis use and purchase behaviours in Canada, United States, Australia, and New Zealand: Findings from the International Cannabis Policy Study
10:50
to
12:20
Knowledge market 1 (K1)
Structured session
Current international evidence on prevalence and perceptions of Heated Tobacco Products (HTPs)
10:50
to
12:20
Insights zone 4 (I4)
Structured session
From Harm to Risk Reduction: OKANA’s 360o approach in Athens
10:50
to
12:20
Knowledge market 4 (K4)
Structured session
How can we improve global coverage of interventions to reduce drug-related harms?
10:50
to
12:20
Main stage
Structured session
Interventions in Community
10:50
to
12:20
Networking zone 1 (N1)
e-poster guided tour
Media Representations and depictions of drug use, addiction and drug markets
10:50
to
12:20
Insights zone 1 (I1)
InterGLAM cinema
Neurology and neuropsychology
10:50
to
12:20
Central square 3 (C3)
Oral presentation session
New frontiers of harm reduction in drug policy
10:50
to
12:20
Networking zone 2 (N2)
e-poster guided tour
Online and social identities
10:50
to
12:20
Insights zone 2 (I2)
Oral presentation session
Practitioners informing practice
10:50
to
12:20
Knowledge market 3 (K3)
Oral presentation session
Problematic internet and videogame use
10:50
to
12:20
Insights zone 3 (I3)
Oral presentation session
Studying illegal drugs in socially embedded markets
10:50
to
12:20
Central square 2 (C2)
Structured session
Substance use and trauma
10:50
to
12:20
Knowledge market 2 (K2)
Oral presentation session
Successful systemic management for addiction challenges and all its side effects
10:50
to
12:20
Central square 4 (C4)
Structured session
Understanding women's drug use, responses and recovery
10:50
to
12:20
Networking zone 4 (N4)
Short communication session
12:20
WHO lunch-time session
Public health dimensions of psychoactive drugs and addictive behaviours in WHO activities and products
12:20
to
13:10
Insights zone 4 (I4)
Lunch break
Lunch break
12:20
to
13:20
Lunch break
13:20
Behavioral addictions: Diverse populations, challenges, and solutions
13:20
to
14:50
Networking zone 1 (N1)
e-poster guided tour
Cannabis and tobacco co-use: A ‘joint’ challenge for research and practice
13:20
to
14:50
Knowledge market 1 (K1)
Structured session
Cannabis Social Clubs: current experiences and future directions
13:20
to
14:50
Knowledge market 4 (K4)
Structured session
Childhood risk factors in substance use and mental health
13:20
to
14:50
Knowledge market 2 (K2)
Oral presentation session
Diversity, stigma, and vulnerability
13:20
to
14:50
Networking zone 4 (N4)
Short communication session
Drug checking in supervised drug consumption room: rationale, methods and results
13:20
to
14:50
Central square 4 (C4)
Structured session
Environmental prevention: why do we need it now and how to advance it?
13:20
to
14:50
Insights zone 2 (I2)
Structured session
Hepatitis C testing and treatment
13:20
to
14:50
Knowledge market 3 (K3)
Oral presentation session
Methods and Problems with Estimating Prevalence of People Who Inject Drugs, studies and debate on how to get better and more consistent estimates in Europe and Rest of the World
13:20
to
14:50
Central square 2 (C2)
Structured session
New Psychoactive Substances
13:20
to
14:50
Insights zone 4 (I4)
Oral presentation session
Novel approaches of alcohol use disorder
13:20
to
14:50
Central square 1 (C1)
Oral presentation session
Shifting markets and drug trafficking
13:20
to
14:50
Networking zone 2 (N2)
e-poster guided tour
Smoking and e-cigarettes
13:20
to
14:50
Central square 3 (C3)
Oral presentation session
The globalised illicit drug market
13:20
to
14:50
Main stage
Structured session
Understanding problematic gambling
13:20
to
14:50
Insights zone 3 (I3)
Oral presentation session
Uppers, downers and psychedelics
13:20
to
14:50
Networking zone 3 (N3)
Short communication session
14:50
Break
14:50
to
15:00
Break
15:00
A global symposium on the renaissance and promise of psychedelics for mental and substance use disorder treatment
15:00
to
16:30
Main stage
Structured session
Alcohol epidemiology and interventions
15:00
to
16:30
Networking zone 3 (N3)
Short communication session
Client-centered approaches
15:00
to
16:30
Central square 3 (C3)
Oral presentation session
Drug and alcohol treatment
15:00
to
16:30
Networking zone 1 (N1)
e-poster guided tour
Drug deaths: A social, structural and systems analysis
15:00
to
16:30
Knowledge market 1 (K1)
Structured session
Implementing Methamphetamine Prevention Strategies into Action (IMPRESA)
15:00
to
16:30
Knowledge market 4 (K4)
Structured session
Insights into acute recreational drug and new psychoactive substance toxicity – an update from the Euro-DEN Plus Project
15:00
to
16:30
Central square 2 (C2)
Structured session
Models to improve the health of people who inject drugs
15:00
to
16:30
Knowledge market 3 (K3)
Oral presentation session
InterGLAM video session
Policy and practice to tackle addictions around the world
15:00
to
16:30
Insights zone 1 (I1)
InterGLAM cinema
Prevention, testing and treatment of Hepatitis C and other infections
15:00
to
16:30
Networking zone 4 (N4)
Short communication session
Preventions interventions
15:00
to
16:30
Insights zone 2 (I2)
Oral presentation session
Substance use and mental health during COVID-19
15:00
to
16:30
Knowledge market 2 (K2)
Oral presentation session
The future of surveys in the field of alcohol research: Lessons learned from a large-scale European survey (DEEP SEAS project)
15:00
to
16:30
Central square 1 (C1)
Structured session
The global gambling industry: Structures, tactics, and networks of impact
15:00
to
16:30
Insights zone 3 (I3)
Structured session
The implementation and evaluation of “safer supply” programs in Canada as a response to an ongoing overdose crisis
15:00
to
16:30
Insights zone 4 (I4)
Structured session
Understanding relationships between substance use, mental health and mental illness: Session 2
15:00
to
16:30
Networking zone 2 (N2)
e-poster guided tour
16:30
Coffee break
16:30
to
16:50
Coffee break
16:50
Alcohol & implementation
16:50
to
18:20
Networking zone 4 (N4)
Short communication session
InterGLAM video session
Different approaches for different populations
16:50
to
18:20
Insights zone 1 (I1)
InterGLAM cinema
How to develop global surveys, guidelines, checklists and consensus statements in prevention and treatment of addiction: new innovations in the pandemic era
16:50
to
18:20
Insights zone 4 (I4)
Structured session
Informing and delivering treatment
16:50
to
18:20
Networking zone 3 (N3)
Short communication session
Innovative approaches to tackling the drug overdoses
16:50
to
18:20
Knowledge market 1 (K1)
Oral presentation session
Insights from treatment I
16:50
to
18:20
Central square 3 (C3)
Oral presentation session
New frontiers to regulating cannabis for public health and social justice
16:50
to
18:20
Insights zone 2 (I2)
Oral presentation session
Opportunities and challenges for countries in transition to overcome barriers to evidence-based policies and interventions
16:50
to
18:20
Networking zone 2 (N2)
Structured session
Prison and drugs: exploring social determinants and pathways to drug problem and incarceration
16:50
to
18:20
Central square 1 (C1)
Structured session
Problem gambling: models and their ethical implications
16:50
to
18:20
Insights zone 3 (I3)
Structured session
Reducing harm - obstacles and opportunities
16:50
to
18:20
Networking zone 1 (N1)
e-poster guided tour
Signals from the future: Exploring implications for drug policies
16:50
to
18:20
Central square 4 (C4)
Workshop
Substance use, suicide and self-harm: epidemiology and prevention
16:50
to
18:20
Main stage
Structured session
Trajectories of cannabis use during periods of policy change
16:50
to
18:20
Central square 2 (C2)
Oral presentation session
Treatment for cannabis use disorder: an update focusing in cultural characteristics
16:50
to
18:20
Knowledge market 4 (K4)
Structured session
Unpacking the neurobiology of cannabis use disorders and cannabinoids: findings from neuroimaging and experimental studies across different ages and world regions
16:50
to
18:20
Knowledge market 2 (K2)
Structured session
Young people, substance use and prevention
16:50
to
18:20
Knowledge market 3 (K3)
Oral presentation session
18:20
Break
18:20
to
18:30
Break
18:30
Addiction, compulsive behaviours and unhealthy habits - A common aetiology and implications for practice?
18:30
to
19:30
Main stage
Big debate
On the path towards elimination of hepatitis C – Models of care to reach people who inject drugs for testing and treatment
18:30
to
19:30
Knowledge market 4 (K4)
Structured session
19:30
Networking buffet dinner
19:30
to
22:00
Fri 25 Nov
09:00
Alcohol addiction; new knowledge on politics, risks, treatments and outcomes
Social inequality in drinking, underage drinking and alcohol industry
09:00
to
10:30
Main stage
Plenary session
Insights from treatment II
09:00
to
10:30
Central square 2 (C2)
Oral presentation session
e-posters — day 3
09:00
to
14:50
Digital kiosks
e-poster session
e-short communications — day 3
09:00
to
14:50
Digital kiosks
e-short communication session
10:30
Coffee break
10:30
to
10:50
Coffee break
10:50
Global Issues - Backcasting exercise
10:50
to
12:20
Insights zone 1 (I1)
InterGLAM cinema
A Digital Future? Engaging online communities of people who use drugs to influence policy and practice
10:50
to
12:20
Central square 4 (C4)
Workshop
EUFAS/EAR European Addiction Award
Alcohol - no ordinary commodity, alcohol policies and The Gut-Brain Axis in AUD
10:50
to
12:20
Main stage
Structured session
Associations of alcohol and substance use with mental health
10:50
to
12:20
Knowledge market 2 (K2)
Structured session
COVID-19-adapted addiction services and impact for service users
10:50
to
12:20
Insights zone 4 (I4)
Structured session
Gambling, policies and interventions
10:50
to
12:20
Insights zone 3 (I3)
Oral presentation session
Gender differences and gender identities in drug use, addiction and interventions: why gender matters
10:50
to
12:20
Networking zone 3 (N3)
Structured session
Harm reduction or prevention?
10:50
to
12:20
Insights zone 2 (I2)
Oral presentation session
Interventions in Academia
10:50
to
12:20
Networking zone 1 (N1)
e-poster guided tour
Investigating adolescent substance use and risk behaviours in the Mediterranean region: where do we stand?
10:50
to
12:20
Networking zone 4 (N4)
Structured session
Language values and theory in drugs policy reform
10:50
to
12:20
Knowledge market 1 (K1)
Oral presentation session
Mortality among people who use drugs
10:50
to
12:20
Knowledge market 3 (K3)
Oral presentation session
Portuguese Drug Policy Model. Achievements and challenges
10:50
to
12:20
Central square 2 (C2)
Structured session
Recreational drug use and risk
10:50
to
12:20
Central square 3 (C3)
Oral presentation session
Substance use and prison
10:50
to
12:20
Central square 1 (C1)
Oral presentation session
Substance use and sexual behaviours
10:50
to
12:20
Knowledge market 4 (K4)
Oral presentation session
Technological addictions in the 21st century
10:50
to
12:20
Networking zone 2 (N2)
e-poster guided tour
12:20
Lunch break
12:20
to
13:20
Lunch break
13:20
Alcohol psychology and some epidemiology
13:20
to
14:50
Networking zone 4 (N4)
Short communication session
Barriers in the implementation of harm reduction interventions in European prisons. From evidence to practice
13:20
to
14:50
Main stage
Structured session
Behavioral addictions
13:20
to
14:50
Insights zone 3 (I3)
Short communication session
Challenging issues for drug research
13:20
to
14:50
Central square 1 (C1)
Oral presentation session
Changes and trends in how people are buying drugs
13:20
to
14:50
Insights zone 4 (I4)
Oral presentation session
Cross-domain prevention: Preventing substance use (disorders) and antisocial behaviour together, importance of intersectoral action in prevention
13:20
to
14:50
Insights zone 2 (I2)
Structured session
InterGLAM Video Contest Award Ceremony
13:20
to
14:50
Insights zone 1 (I1)
InterGLAM cinema
Navigating the future of supervised consumption research and intervention: European and North American experiences
13:20
to
14:50
Central square 2 (C2)
Structured session
New advances in alcohol clinical research: evidence from three large National Institute for Health Research-funded randomised controlled trials
13:20
to
14:50
Networking zone 3 (N3)
Structured session
Overdose prevention
13:20
to
14:50
Knowledge market 3 (K3)
Oral presentation session
Stress and Addiction: Updates on the Chicken or Egg question
13:20
to
14:50
Central square 4 (C4)
Structured session
Substance use consequences and concerns
13:20
to
14:50
Networking zone 1 (N1)
e-poster guided tour
Substance use, mental health risk and suicide
13:20
to
14:50
Knowledge market 2 (K2)
Oral presentation session
The experience of persons in homeless situation with alcohol related problems regarding a pharmacological harm reduction initiative
13:20
to
14:50
Knowledge market 4 (K4)
Structured session
Understanding drug use, risk and harm
13:20
to
14:50
Networking zone 2 (N2)
e-poster guided tour
Using innovative data or methods to assess drug markets and drug policy impacts
13:20
to
14:50
Knowledge market 1 (K1)
Oral presentation session
Working with the most vulnerable
13:20
to
14:50
Central square 3 (C3)
Oral presentation session
14:50
Break
14:50
to
15:00
Break
15:00
The Richard Hartnoll memorial lecture
15:00
to
15:30
Main stage
Plenary session
15:30
Closing keynote: Providing care in a time of war — perspectives from Ukraine
15:30
to
16:00
Main stage
Plenary session
16:00
Closing remarks
16:00
to
16:30
Main stage
Plenary session
Back to top